N/A
Manufactured by Sandoz Inc
21,426 FDA adverse event reports analyzed
Last updated: 2026-04-14
BRINZOLAMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Sandoz Inc. The most commonly reported adverse reactions for BRINZOLAMIDE include TREATMENT FAILURE, DYSPNOEA, DRUG INEFFECTIVE, DIZZINESS, EYE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BRINZOLAMIDE.
Out of 8,461 classified reports for BRINZOLAMIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 21,426 FDA FAERS reports that mention BRINZOLAMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include TREATMENT FAILURE, DYSPNOEA, DRUG INEFFECTIVE, DIZZINESS, EYE PAIN, DIARRHOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Sandoz Inc in connection with BRINZOLAMIDE. Always verify the specific product and NDC with your pharmacist.